EIB Group (EIB & EIF) guarantee to UniCredit to mobilise approximately €2 billion in support of Italian SMEs and Mid-caps. The operation is supported by a guarantee from the European Fund for Strategic Investments (EFSI) — the main pillar of … Read the full press release
€125 million loan granted to BATIGERE Network subsidiary dedicated to building affordable housing in France 1 500 home builds planned over five years for 3 500 residents Operation guaranteed by the European Fund for Strategic Investments (EFSI) (PRESS RELEASE) KIRCHBERG, Luxembourg, 11-Jan-2021 — … Read the full press release
Posted in Banks, Construction, Financial, France, Infrastructure & Utilities, Investment, Luxembourg, News, Real Estate
Tagged affordable housing in France, Ambroise Fayolle, BATIGERE Network, construction, EFSI, EIB, EIB loan, EU climate bank, European Fund for Strategic Investments, European Investment Bank, financing, Grand Est, housing, Île-de-France, Livie, low-rent housing cooperative, Lyon, Marseille, middle-income workers, Nantes, Nice, Paolo Gentiloni, Paris, Pascal Barbottin, Pau, Rhône-Alpes, Strasbourg, Sud, Toulouse
Financing deal worth €15.0 million signed to support clinical development programme for masitinib Masitinib developed as a credible candidate for treating COVID-19 in addition to other diseases for which no therapeutic solutions are available (PRESS RELEASE) PARIS, 30-Nov-2020 — /EuropaWire/ — … Read the full press release
Posted in Banks, European Union, Financial, France, Healthcare, Investment, Luxembourg, News, Pharma & Biotech, Small Business
Tagged 3CL protease, AB Science SA, Alain Moussy, Ambroise Fayolle, anti-inflammatory, antiviral, chemotherapy, COVID-19, COVID-19 treatment, EIB, European Commission, European Fund for Strategic Investments, European Investment Bank, European Union, financing, health crisis, Horizon 2020, immunotherapeutic, inflammatory disease, innovationm, InnovFin, investments, kinase inhibitors, kinases, loan, macrophages, masitinib, microglia, neurological diseases, oncology, PKIs, RESEARCH, SARS-CoV-2, tyrosine kinase inhibitor
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
